Simplex Trading’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$72.7M Sell
2,587,600
-1,148,800
-31% -$30.6M 0.05% 157
2025
Q4
$93M Sell
3,736,400
-245,100
-6% -$6.18M 0.05% 165
2025
Q3
$101M Sell
3,981,500
-42,900
-1% -$1.06M 0.05% 186
2025
Q2
$97.6M Sell
4,024,400
-627,400
-13% -$14.6M 0.06% 164
2025
Q1
$118M Sell
4,651,800
-390,200
-8% -$10.2M 0.08% 124
2024
Q4
$134M Sell
5,042,000
-428,700
-8% -$11.6M 0.07% 133
2024
Q3
$158M Sell
5,470,700
-335,400
-6% -$9.78M 0.09% 101
2024
Q2
$162M Sell
5,806,100
-914,300
-14% -$25.2M 0.1% 90
2024
Q1
$186M Buy
6,720,400
+1,674,100
+33% +$46.5M 0.11% 85
2023
Q4
$145M Buy
5,046,300
+2,204,800
+78% +$66.7M 0.09% 110
2023
Q3
$94.3M Buy
2,841,500
+448,000
+19% +$15.8M 0.07% 145
2023
Q2
$87.8M Buy
2,393,500
+668,400
+39% +$26M 0.07% 163
2023
Q1
$70.4M Sell
1,725,100
-963,300
-36% -$41.6M 0.06% 218
2022
Q4
$133M Buy
2,688,400
+271,300
+11% +$13M 0.15% 98
2022
Q3
$102M Sell
2,417,100
-245,500
-9% -$11.9M 0.12% 114
2022
Q2
$128M Sell
2,662,600
-1,525,200
-36% -$77.7M 0.14% 81
2022
Q1
$205M Buy
4,187,800
+445,000
+12% +$23.1M 0.19% 61
2021
Q4
$196M Buy
3,742,800
+118,700
+3% +$5.88M 0.2% 72
2021
Q3
$123M Buy
3,624,100
+32,500
+0.9% +$1.44M 0.11% 111
2021
Q2
$121M Buy
3,591,600
+3,559,666
+11,147% +$138M 0.12% 110
2021
Q1
$86.7M Buy
31,934
+9,102
+40% +$323K 0.16% 83
2020
Q4
$34.8M Buy
22,832
+5,356
+31% +$196K 0.05% 234
2020
Q3
$60.9M Buy
17,476
+3,294
+23% +$115K 0.08% 136
2020
Q2
$44M Buy
14,182
+7,797
+122% +$265K 0.07% 154
2020
Q1
$19.8M Buy
6,385
+1,133
+22% +$38.6K 0.03% 241
2019
Q4
$19.5M Sell
5,252
-1,782
-25% -$63.5K 0.04% 278
2019
Q3
$24M Buy
7,034
+386
+6% +$14K 0.07% 210
2019
Q2
$27.3M Buy
6,648
+1,080
+19% +$42.9K 0.07% 179
2019
Q1
$22.4M Buy
5,568
+622
+13% +$24.9K 0.06% 194
2018
Q4
$20.5M Buy
4,946
+3,090
+166% +$128K 0.06% 197
2018
Q3
$7.76M Sell
1,856
-39
-2% -$1.5K 0.02% 447
2018
Q2
$6.52M Sell
1,895
-1,070
-36% -$36.6K 0.03% 468
2018
Q1
$430K Buy
2,965
+1,705
+135% +$58.6K 0.02% 789
2017
Q4
$62K Sell
1,260
-876
-41% -$29.9K ﹤0.01% 2236
2017
Q3
$221K Sell
2,136
-2,934
-58% -$94.3K 0.01% 1128
2017
Q2
$647K Buy
5,070
+1,983
+64% +$62.5K 0.03% 530
2017
Q1
$366K Sell
3,087
-632
-17% -$19.9K 0.02% 853
2016
Q4
$585K Buy
3,719
+1,715
+86% +$52.4K 0.04% 467
2016
Q3
$326K Sell
2,004
-1,143
-36% -$38.2K 0.02% 726
2016
Q2
$251K Sell
3,147
-6,195
-66% -$198K 0.02% 867
2016
Q1
$1.73M Buy
9,342
+4,087
+78% +$117K 0.14% 135
2015
Q4
$903K Buy
5,255
+2,550
+94% +$80.2K 0.07% 244
2015
Q3
$188K Buy
2,705
+2,368
+703% +$75.9K 0.01% 955
2015
Q2
$26K Buy
337
+123
+57% +$4.01K ﹤0.01% 2234
2015
Q1
$14K Sell
214
-7
-3% -$223 ﹤0.01% 2633
2014
Q4
$76K Buy
+221
New +$6.34K 0.01% 1098

Other funds holding PFE

Simplex Trading's PFE Position: Q1 2026 in Review

Simplex Trading reduced its Pfizer (PFE) stake by 15% in Q1 2026, selling an estimated $5.97M and leaving 1,266,685 shares worth $35.6M. The position accounts for 0.02% of the portfolio, ranked #292.

Simplex Trading first reported a position in PFE in Q2 2015 and has held it in 34 quarters since. The position peaked at $128M in Q1 2024. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Simplex Trading held 1,266,685 shares of Pfizer worth $35.6M as of Q1 2026.
  • Simplex Trading sold 224,352 Pfizer shares in Q1 2026, an estimated $5.97M.
  • Pfizer made up 0.02% of Simplex Trading's portfolio in Q1 2026, its #292 holding.
  • Simplex Trading first reported a position in Pfizer in Q2 2015 and has held it in 34 quarters since.
  • Simplex Trading's Pfizer position peaked at $128M in Q1 2024.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.